Lineage Cell Therapeutics
LCTX
#8742
Rank
C$0.17 B
Marketcap
$0.77
Share price
-1.91%
Change (1 day)
-47.89%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Net assets

Net assets on the balance sheet as of September 2024 : C$93.18 Million

According to Lineage Cell Therapeutics 's latest financial reports the company has C$93.18 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lineage Cell Therapeutics - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$C$82.26 M-15.72%
2022-12-31$C$97.61 M-15.74%
2021-12-31$C$0.11 B-4.49%
2020-12-31$C$0.12 B-16.52%
2019-12-31$C$0.14 B15.63%
2018-12-31$C$0.12 B-39.15%
2017-12-31$C$0.20 B17.75%
2016-12-31$C$0.17 B65.38%
2015-12-31$C$0.10 B45.69%
2014-12-31$C$72.78 M61.8%
2013-12-31$C$44.98 M86.22%
2012-12-31$C$24.15 M-42.71%
2011-12-31$C$42.17 M-14.64%
2010-12-31$C$49.4 M325.05%
2009-12-31$C$11.62 M-319.92%
2008-12-31$-C$5.29 Million73.91%
2007-12-31$-C$3.04 Million39.94%
2006-12-31$-C$2.18 Million848.87%
2005-12-31$-C$0.23 Million-155.27%
2004-12-31$C$0.41 M-113.13%
2003-12-31$-C$3.16 Million70.45%
2002-12-31$-C$1.85 Million1071.73%
2001-12-31$-C$0.16 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$0.39 B 322.87%๐Ÿ‡บ๐Ÿ‡ธ USA